Bactericidal and Bioresorbable Calcium Phosphate Cements Fabricated by Silver-Containing Tricalcium Phosphate Microspheres.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 May 2020
Historique:
received: 15 04 2020
revised: 19 05 2020
accepted: 22 05 2020
entrez: 30 5 2020
pubmed: 30 5 2020
medline: 17 2 2021
Statut: epublish

Résumé

Bacterial adhesion to the calcium phosphate surface is a serious problem in surgery. To prevent bacterial infection, the development of calcium-phosphate cements (CPCs) with bactericidal properties is indispensable. The aim of this study was to fabricate antibacterial CPCs and evaluate their biological properties. Silver-containing tricalcium phosphate (Ag-TCP) microspheres consisting of α/β-TCP phases were synthesized by an ultrasonic spray-pyrolysis technique. The powders prepared were mixed with the setting liquid to fabricate the CPCs. The resulting cements consisting of β-TCP and hydroxyapatite had a porous structure and wash-out resistance. Additionally, silver and calcium ions could be released into the culture medium from Ag-TCP cements for a long time accompanied by the dissolution of TCP. These data showed the bioresorbability of the Ag-TCP cement. In vitro antibacterial evaluation demonstrated that both released and immobilized silver suppressed the growth of bacteria and prevented bacterial adhesion to the surface of CPCs. Furthermore, histological evaluation by implantation of Ag-TCP cements into rabbit tibiae exhibited abundant bone apposition on the cement without inflammatory responses. These results showed that Ag-TCP cement has a good antibacterial property and good biocompatibility. The present Ag-TCP cements are promising for bone tissue engineering and may be used as antibacterial biomaterials.

Identifiants

pubmed: 32466460
pii: ijms21113745
doi: 10.3390/ijms21113745
pmc: PMC7312163
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bone Cements 0
Calcium Phosphates 0
Hydroxyapatites 0
Silver 3M4G523W1G
tricalcium phosphate K4C08XP666

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Antimicrob Agents. 2009 Aug;34(2):103-10
pubmed: 19339161
Expert Rev Med Devices. 2009 Sep;6(5):553-67
pubmed: 19751126
J Control Release. 2017 Apr 28;252:1-17
pubmed: 28232225
J Mater Sci Mater Med. 2001 Feb;12(2):135-9
pubmed: 15348319
J Biomed Mater Res A. 2007 Oct;83(1):80-7
pubmed: 17380498
J Biomed Mater Res. 2000 Dec 15;52(4):662-8
pubmed: 11033548
Nat Rev Microbiol. 2015 Jan;13(1):42-51
pubmed: 25435309
J Biomed Mater Res A. 2004 Mar 15;68(4):725-34
pubmed: 14986327
J Insect Physiol. 2008 Jun;54(6):1090-7
pubmed: 18513740
J Biomed Mater Res A. 2009 Jan;88(1):246-54
pubmed: 18286618
Sci Rep. 2018 Mar 26;8(1):5216
pubmed: 29581559
Biomaterials. 2005 Nov;26(33):6423-9
pubmed: 15964620
J Biomed Mater Res A. 2015 Jan;103(1):57-64
pubmed: 24616120
J Biomater Appl. 2003 Apr;17(4):253-64
pubmed: 12797418
Acta Biomater. 2012 Apr;8(4):1401-21
pubmed: 22127225
Mater Sci Eng C Mater Biol Appl. 2013 Dec 1;33(8):5008-18
pubmed: 24094218
Clin Orthop Relat Res. 2002 Feb;(395):81-98
pubmed: 11937868
Biomaterials. 2000 Dec;21(23):2405-12
pubmed: 11055288
J Control Release. 2006 Jun 28;113(2):102-10
pubmed: 16740332
Acta Biomater. 2011 Nov;7(11):4064-70
pubmed: 21763795
J Biomed Mater Res. 1998 Feb;39(2):308-16
pubmed: 9457562
Adv Drug Deliv Rev. 2007 May 30;59(4-5):234-48
pubmed: 17478007
Acta Biomater. 2011 Apr;7(4):1431-40
pubmed: 21056701
Int J Nanomedicine. 2018 Jun 05;13:3311-3327
pubmed: 29892194
J Mech Behav Biomed Mater. 2020 Mar;103:103565
pubmed: 32090955
Nat Rev Microbiol. 2018 Jul;16(7):397-409
pubmed: 29720707
J R Soc Interface. 2011 Apr 6;8(57):529-39
pubmed: 20880853
J Biomed Mater Res. 1998 Winter;43(4):399-409
pubmed: 9855198
J Bone Joint Surg Am. 1998 Aug;80(8):1112-24
pubmed: 9730120
J Biomed Mater Res. 2001 Dec 5;57(3):457-66
pubmed: 11523041
Biomaterials. 2005 Apr;26(12):1337-48
pubmed: 15482821
J Colloid Interface Sci. 2004 Jul 1;275(1):177-82
pubmed: 15158396

Auteurs

Michiyo Honda (M)

Department of Applied Chemistry, School of Science and Technology, Meiji University, Kanagawa 214-8571, Japan.

Yusuke Kawanobe (Y)

Department of Applied Chemistry, School of Science and Technology, Meiji University, Kanagawa 214-8571, Japan.

Kohei Nagata (K)

Department of Applied Chemistry, School of Science and Technology, Meiji University, Kanagawa 214-8571, Japan.

Ken Ishii (K)

Department of Orthopedic Surgery, School of Medicine, International University of Health and Welfare Mita Hospital, 1-4-3, Mita, Minato-ku, Tokyo 108-8329, Japan.

Morio Matsumoto (M)

Department of Orthopaedic Surgery, School of Medicine, Keio University, Tokyo 160-8582, Japan.

Mamoru Aizawa (M)

Department of Applied Chemistry, School of Science and Technology, Meiji University, Kanagawa 214-8571, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH